TTTakahiro Tamura

Takahiro Tamura

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Takahiro Tamura has a total of 107 co-authors. Here are the top co-authors by number of shared publications:

  • Kimitoshi Nishiwaki

    Department of Anesthesiology, Nagoya University Graduate School of Medicine, Nagoya, Japan

    23 shared publications
  • Shuichi Yokota

    Division of Anesthesiology, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya, Japan

    10 shared publications
  • Yoko Kubo

    Department of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan

    9 shared publications
  • Masahiko Ando

    Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan

    8 shared publications
  • Shogo Suzuki

    Department of Anesthesiology, Nagoya University Graduate School of Medicine, Nagoya, Japan

    6 shared publications
  • Atsushi Mori

    Department of Perioperative Management System, Nagoya University Graduate School of Medicine, Nagoya, Japan

    5 shared publications

Latest Publications

  • Open Access

    Planned preoperative plasma exchange for cesarean delivery in a pregnant woman with Child–Pugh class C cirrhosis: a case report and literature review

    by Fumiaki Obayashi, Takahiro Tamura, Yasuhiro Amano, Tasuku Fujii, Koichi Akiyama, Shogo Suzuki

    Background: Pregnancy complicated by Child–Pugh class C cirrhosis is rare and poses major challenges because correction of severe coagulopathy may worsen fluid overload. Case presentation: A 40-year-old pregnant woman with cirrhosis suspected to be secondary to autoimmune hepatitis developed severe hypofibrinogenemia, thrombocytopenia, and marked fluid overload. Her liver disease progressed to Child–Pugh class C, and planned cesarean delivery was scheduled at 26 weeks and 6 days of gestation. Plasma exchange using fresh frozen plasma was performed once daily for 3 consecutive days before surgery, together with albumin, diuretics, and targeted coagulation factor replacement. Cesarean delivery was completed despite an estimated blood loss of 3,650 mL. The patient was extubated in the operating room and discharged home on postoperative day 15. The infant was discharged home on postnatal day 122 and subsequently showed generally appropriate growth and neurodevelopment. Conclusion: Planned preoperative plasma exchange may be a useful bridge to controlled delivery in selected pregnancies complicated by severe decompensated cirrhosis.

  • Open Access

    Environmental and clinical rationale for the use of desflurane: a review of the literature

    by Takahiro Tamura, Takahiro Ando

    Desflurane is a fluorinated ether anesthetic with several clinical benefits, including resistance to defluorination (reducing nephrotoxicity), rapid emergence, cardioprotective properties, and faster recovery of airway reflexes than other volatile agents. However, its use is increasingly restricted because of environmental concerns, and the European Union has finalized regulations to phase out its use from January 2026, citing its global warming potential. Although its 100-year global warming potential exceeds that of comparable agents, the most appropriate emission metric remains debated. Radiative forcing estimates indicate that current atmospheric concentrations of desflurane contribute approximately 0.00014 W/m2, compared with 2.33 W/m2 for CO2, suggesting a minimal overall impact. Since sevoflurane yields lower values for all indicators, it should be prioritized when volatile anesthetics are used, whereas desflurane should be reserved for specific situations. Moreover, alternative anesthetics, including intravenous agents, have their own environmental burdens related to plastic waste, drug disposal, and energy consumption, indicating that restricting desflurane alone will not eliminate anesthetic-related environmental impacts. This review assesses the balance between desflurane’s clinical utility and environmental effects, identifies contexts in which it offers clinical advantages, summarizes its greenhouse gas contributions, and discusses mitigation strategies, including low-flow anesthesia, anesthetic gas capture and recycling. Judicious, environmentally conscious use of desflurane may allow it to remain an additional anesthetic option in selected clinical contexts, alongside other inhaled and intravenous anesthetics, while efforts to minimize its environmental footprint continue. Graphical abstract The alternative text for this image may have been generated using AI.


  • Open Access

    Remimazolam-based anesthesia with intraoperative motor evoked potential monitoring in a patient with Leigh syndrome undergoing scoliosis surgery: a case report

    by Takahiro Kuwabara, Takahiro Tamura, Masashi Takakura, Tasuku Fujii, Kanako Ozeki, Koichi Akiyama

    Background: We present a case of scoliosis surgery performed under general anesthesia with remimazolam in a 16-year-old patient with Leigh syndrome (LS), a subtype of mitochondrial encephalomyopathy. Anesthetic management in such patients is challenging because of the risks of malignant hyperthermia with inhalational agents and propofol infusion syndrome, and because many of these patients present with impaired consciousness and respiratory compromise, anesthetic management becomes extremely difficult. To date, very few reports have described remimazolam use in LS, and none have described cases requiring intraoperative motor-evoked potential (MEP) monitoring. Case presentation: A patient diagnosed with LS at 7 months of age underwent corrective scoliosis surgery. Anesthesia was induced and maintained using remimazolam supplemented with opioids and muscle relaxants. Some intraoperative MEP signals were attenuated but remained monitorable. The patient was extubated with flumazenil and admitted to the intensive care unit, where a transient decrease in oxygenation was observed. However, the patient recovered without any complications and was discharged uneventfully. Conclusion: Remimazolam may be a feasible anesthetic option for patients with LS undergoing surgery requiring MEP monitoring. However, its use should be carefully determined based on factors such as the patient’s age, level of consciousness, respiratory function, and history of epilepsy.


  • Open Access

    Objective evaluation of facial flushing for mesenteric traction syndrome diagnosis during laparotomy: a prospective observational pilot study

    by Yutaro Ikki, Takeshi Negita, Kimitoshi Nishiwaki, Takahiro Tamura

    Background: We aimed to evaluate the concordance between facial flushing assessment using an objective color sensor and subjective visual assessment in patients with mesenteric traction syndrome (MTS), to inform the design of a future large-scale study that incorporates objective diagnostic tools. Methods: In this prospective pilot study, we enrolled adult patients who underwent pancreatectomy. Anesthesiologists assessed the degree of facial flushing subjectively using a scale of levels 0–2. Simultaneously, the Nix color sensor objectively measured the facial redness (a-value) at four facial points. Heart rate and arterial blood pressure were also recorded. Based on the anesthesiologist’s diagnosis, patients were categorized into either the MTS or non-MTS group. We compared the ratio of changes in a-value, heart rate, and blood pressure between the two groups, and their thresholds were also calculated. Results: We included 38 patients: 14 in the MTS group and 24 in the non-MTS group. The MTS group showed significantly higher median change ratio in a-value (0.45 vs. 0.25, P = 0.02) and heart rate (0.45 vs. 0.23, P < 0.01) and a greater decrease in mean arterial pressure (-0.26 vs. -0.14, P = 0.01) than the non-MTS group. Subjective flushing levels correlated with MTS diagnosis ( P < 0.01). While the Nix sensor detected flushing in some subjectively undiagnosed cases, one patient in the non-MTS group met all three objective thresholds. Conclusion: Objective evaluation of facial flushing using a color sensor is feasible and may enhance conventional assessment methods. To further improve the accuracy of objective evaluation, this pilot study may lead to a larger-scale study including blood tests.

  • Open Access

    Videos for informed consent enable task shifting while enhancing patient safety and satisfaction: a retrospective study

    by Akitoshi Hatahira, Akiko Sekiguchi, Fumimasa Kitano, Hiroo Yamamoto, Masaru Kurihara, Tomomi Umemura, Yoshimasa Nagao, Kimitoshi Nishiwaki, Takahiro Tamura

    Informed consent with video assistance provides patients with standardized information regarding complex clinical procedures. We explored the potential of

  • Open Access

    Changes in blood concentration of tranexamic acid in dialysis and non-dialysis patients undergoing cardiac surgery: a prospective observational cohort study

    by Takahiro Tamura, Tatsuro Yokoyama, Tsuyoshi Nakai, Yasuhiro Miyagawa, Kimitoshi Nishiwaki

    The pharmacokinetics of tranexamic acid (TXA), used during cardiopulmonary bypass (CPB) surgery, in patients receiving maintenance hemodialysis remain unclear. This prospective study compared serum tranexamic acid (TXA) concentrations following bolus administration and subsequent intensive care unit (ICU) admission in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB), including those receiving maintenance hemodialysis and those not on dialysis. Participants received two TXA boluses: 1000 mg (500 mg for patients receiving hemodialysis) at procedure initiation and another 1000 mg (500 mg for patients receiving hemodialysis) after CPB withdrawal. Blood samples were collected at 30, 60, and 120 min, and after CPB weaning after the first dose; following the second dose; upon ICU admission; and at 4, 8, and 12 h post-ICU admission to measure TXA concentrations. A renal function-based simulation model was developed to optimize TXA dosing. Among 82 patients (74 without dialysis and 8 receiving hemodialysis), serum TXA concentrations were similar between groups until ICU admission. Following CPB withdrawal, patients receiving hemodialysis exhibited higher TXA concentrations than non-dialysis patients, despite receiving only half the total dose. TXA concentrations remained significantly higher in hemodialysis patients after ICU admission. Bolus administration effectively maintained antifibrinolytic TXA levels (> 10 µg/mL). The renal function-based model guides optimal TXA dosing strategies.

  • Confronting clinical tradition: ipsilateral arm use after breast cancer surgery in Japan

    by Takahiro Tamura

    The long-standing practice of prohibiting ipsilateral arm use for intravenous access, blood draws, or blood pressure monitoring after breast cancer surgery has persisted in many countries and remains common in some Japanese institutions, often based on routine signage and overly simplified education. While historically justified in the era of Halsted’s radical mastectomy owing to high postoperative lymphedema rates, today’s surgical landscape, with the increasing use of breast-conserving surgery and sentinel lymph node biopsy (SLNB), has seen a marked decline in clinically significant arm swelling. Recent large retrospective studies and society statements (Society for Ambulatory Anesthesia, American Society of Breast Surgeons, and Australian and New Zealand College of Anaesthetists) support risk-based, individualized assessments rather than blanket exclusion. This article examines the cultural, educational, and systemic factors that maintain outdated restrictions and presents a symptom-guided risk stratification framework. Asymptomatic patients 1 year after SLNB or 3 years after axillary lymph node dissection/regional lymph node radiation are at low risk for access-related complications. This article explores the unintended harm of rigid policies, including compromised access, delay in care, and patient distress, and proposes strategies for institution-level policy revision and patient education. Shifting from prohibition to personalization aligns clinical practice with modern evidence, promotes patient autonomy, and prevents the perpetuation of outdated norms. Graphical abstract

  • The TEG6s-Derived R ratio accurately reflects the anti-Xa level after cardiac surgery: A proof-of-concept study

    by Takahiro Tamura, Tatsuro Yokoyama

    Introduction: In the postoperative intensive care setting after cardiac surgery with cardiopulmonary bypass (CPB), particularly in patients requiring continued anticoagulation for prosthetic devices such as mechanical valves or extracorporeal support, unfractionated heparin (UFH) is commonly monitored using the activated partial thromboplastin time (aPTT). However, it may inadequately reflect anticoagulant activity in critically ill patients. The TEG6s system is a viscoelastic testing platform that enables bedside coagulation monitoring. This proof-of-concept study aimed to evaluate the utility of TEG6s-derived indices for estimating the anti-Xa level following CPB. Methods: We prospectively enrolled 131 adult patients undergoing elective cardiac or aortic surgery with CPB. Paired blood samples were collected at intensive care unit admission and 4 h later. Heparin concentrations were measured using a chromogenic anti-Xa assay. Thromboelastography (TEG) parameters including the reaction times for the citrated kaolin without and with heparinase assays and their ratio (R ratio) and difference were obtained. Their correlations with the anti-Xa level were assessed using Pearson’s and Spearman’s analyses. Linear and polynomial regression models were used to evaluate predictive performance. Results: The R ratio and reaction time difference showed strong correlations with the plasma anti-Xa level (r = 0.738 and r = 0.733, respectively; p < 0.001). These correlations were comparable to that of the aPTT ratio (r = 0.813). The second-order polynomial regression model using the R ratio had the highest predictive accuracy (R 2 = 0.584, root mean square error = 0.134). Conclusions: The R ratio may be a supplementary indicator of a residual heparin effect, particularly in cases with discordant aPTT findings.